Adgbtm1d(KOMP)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Adgbtm1d(KOMP)Wtsi |
| Name: |
androglobin; targeted mutation 1d, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:7311625 |
| Gene: |
Adgb Location: Chr10:10211453-10348070 bp, - strand Genetic Position: Chr10, 3.44 cM
|
| Alliance: |
Adgbtm1d(KOMP)Wtsi page
|
| IMPC: |
Adgb gene page |
|
| Mutant Cell Line: |
EPD0707_3_H06 |
| Germline Transmission: |
Earliest citation of germline transmission:
J:326350
|
| Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
| Project Collection: |
KOMP-CSD
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 10282651 of Chromosome 10 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 10283721. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele was created by flp recombinase expression in mice carrying this allele. Subsequent cre expression resulted in a knockout mouse. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:326350)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Adgb Mutation: |
90 strains or lines available
|
|
| Original: |
J:326350 Keppner A, et al., Androglobin, a chimeric mammalian globin, is required for male fertility. Elife. 2022 Jun 14;11:e72374 |
| All: |
1 reference(s) |
|